Huawei Turns Niche Smartwatches Into an Everyday Need

BY

-

Sun, 10 Sep 2023 - 03:08 GMT

BY

Sun, 10 Sep 2023 - 03:08 GMT

In 2014, Huawei entered the wearables market with its two-in-one smart band, the HUAWEI TalkBand B1. Since then, the company has developed its smart wearables through the recent launch of the HUAWEI WATCH 4 series, marking 10 years in the smart wearables industry. 
 
WhatsApp Image 2023-09-10 at 4.51.17 PM (1)
 
For the past decade, Huawei has aimed to provide consumers with the best smart wearable products utilising the latest technologies. By focusing on self-driven R&D and foundational scientific research, the brand has produced innovative solutions such as sensors, algorithms, and features. Starting in 2016, Huawei launched its first proprietary optical vital signs monitoring technology, HUAWEI TruSeen™️ 1.0. Following that, Huawei developed its own sensor solutions the following year, enabling wearable devices to support six types of dynamic heart rate monitoring. In 2018, the TruSeen™️ 3.0 notably achieved 24-hour continuous heart rate monitoring. In 2020, a high-performance ECG sensor was incorporated into the hardware module of TruSeen™️ 4.0, breaking new ground with medical-grade electrocardiogram detection capabilities and continuous blood oxygen monitoring functions. The latest TruSeen™️ 5.0+ now offers improved detection accuracy and supports more health research and risk assessment checks. But the brand is not done and is looking to release the next iteration, TruSeen™️ 5.5+ in September this year. Initially only supporting heart rate detection, Huawei has expanded throughout the past 8 years continuously improving and innovating. This led to the introduction of features such as TruSleep™️, TruRelax™️ and TruSport™️ which brings heart rate monitoring, blood oxygen surveillance, and stress tracking which provides a comprehensive overall health management, to the wrists of users.
 
As one of the world’s biggest patent contributors, HUAWEI Health has applied for over 800 patents and published 8 ESC research results under the 2020 ESC Guidelines on Atrial Fibrillation within the past 8 years. In 2022, the HUAWEI WATCH D launched globally, and received CE certification, making it available for use in 33 countries in Europe. It was the industry’s first wearable device that used hybrid blood pressure measurement technology, allowing users to accurately measure their blood pressure through micro pump pressurisation, allowing them to measure their blood pressure at any point in time. 
 
Within the past 10 years, Huawei has accelerated the global growth of professional research in the field of wearable technology. The brand has 10 research institutes and 3 fitness and health laboratories around China, with plans to setup its own health laboratories in Europe later this year. Shipment of Huawei smartwatches has surpassed 130 million units globally, and the HUAWEI Health App has over 450 million active users globally. Huawei smartwatches has dominated more than half of the China market for the past 4 consecutive years , due to the brand’s research into sports and health monitoring capabilities. 
WhatsApp Image 2023-09-10 at 4.51.17 PM (2)
 
“Huawei’s remarkable achievements have only been made possible through our collaborative efforts with industry experts and universities that have brought forth innovative solutions for our smartwatches” said Mr Zhang Wei, CEO of Huawei Health Team, President of Smart Wearable and Health Product Line, Huawei Consumer Business Group, at this year’s Huawei Developers Conference (HDC). 
 
Today, Huawei has studied health data contributed by a user base of more than 5 million for heart health, 810,000 for vascular heath, around 800,000 for respiratory health studies, over 300 million for sleep breathing awareness research and nearly 300,000 for blood pressure health research. 
 

In the development of digital health monitoring, smartwatches play a strategic role in supporting active health management. However, there is still much to be improved when it comes to the accuracy of smartwatches. To enhance the precision of chronic disease detection, Huawei is committed to working with expert institutions and partners. This strategic endeavour aims to nurture the development of solutions and algorithms, ensuring more accurate readings and outcomes. Huawei looks to provide users with an enhanced health monitoring experience, leading the way in the continuous progress of non-intrusive and smart wearable devices that will benefit individuals, families and the industry alike.

 

Comments

0

Leave a Comment

Be Social